Leadership Announcements and New Arcera Structure
Arcera aims to become a global life sciences company, with the purpose of enabling longer and healthier lives while driving sustainable growth. Our strategic imperatives guide our business plans, focusing on creating value, growing organically and building global scale through mergers, acquisitions and partnerships.
This year, Arcera has made significant progress by establishing a robust headquarters and bringing together its complementary businesses: Acino, Amoun Pharmaceutical Company and Birgi Mefar Group. Together, these entities offer over 2,000 branded medicines across a wide range of therapeutic areas, supported by a combined workforce of more than 6,500 people.
Today, to accelerate the implementation of our strategic goals and values consistently across all of our businesses, we are launching One Arcera, a transition toward a single organizational and operational structure that supports our vision of becoming a leading global life sciences company.
Effective 1 January 2025, under the leadership of Isabel Afonso, Chief Executive Officer, Arcera will be organized into two units and a set of core functions:
- Arcera General Medicines, led by Erik Nordkamp as Chief Executive Officer of General Medicines, incorporates all Acino and Amoun commercial operations and their supporting functions for general medicines. This includes branded generics, off-patent originator medicines, innovative medicines and over-the-counter (OTC) products.
- Arcera TechOps, led by Samir El Nasharty as Chief TechOps Officer, integrates all manufacturing and packaging sites, Corporate Quality, Supply Chain capabilities, B2B and TechOps supporting functions across the three current businesses.
- Arcera Core Functions to be functionally led from Headquarters in Abu Dhabi with dual functional reporting lines between the respective units and Arcera Headquarters.
New leaders are joining a highly experienced and well-established Leadership Team, each bringing a unique set of skills and expertise to drive Arcera’s success.
We are laying the foundation for Arcera’s future growth by enhancing agility, operational efficiency and value creation. By consolidating and aligning our vision and resources, while preserving the heritage and trust built by the existing brands that make up Arcera, we are setting the stage for future expansion and innovation in line with our long-term vision.
To learn more about Arcera, please visit www.arceralifesciences.com.